Erich Solomayer
Papers
1
Total Citations
17
H-Index
1
About
Dr. Erich Solomayer is a leading figure in gynecologic oncology, with a research focus that bridges surgical innovation and evidence-based clinical practice. His major contributions center on the critical evaluation of surgical approaches for gynecologic malignancies, particularly early-stage cervical cancer. He is best known for his authoritative commentary on the landmark LACC trial, which demonstrated that minimally invasive radical hysterectomy was associated with poorer outcomes compared to open surgery. As a co-author of the 2018 comment from the German Society for Gynecology and Obstetrics (DGGG), Dr. Solomayer helped translate these pivotal findings into clinical guidelines, directly influencing surgical standards worldwide. This work, cited 17 times, reflects his role as a key voice in shaping discourse on surgical safety. Beyond this, his broader research encompasses fertility preservation in oncology and the optimization of surgical techniques. Dr. Solomayer’s impact is evident in his leadership within the Uterus Commission of the AGO and AGE, where he drives quality assurance and protocol development. For students and researchers, his career exemplifies how rigorous clinical trials and expert commentary can transform patient care in gynecologic oncology.
Research Focus
Key Achievements
Top Papers
- 1